{"name":"LaNova Medicines Limited","slug":"lanova-medicines-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"LM-108 in combination with Toripalimab","genericName":"LM-108 in combination with Toripalimab","slug":"lm-108-in-combination-with-toripalimab","indication":"Solid tumors (specific indications under investigation in Phase 3)","status":"phase_3"},{"name":"Paclitaxel injection intravenous infusion","genericName":"Paclitaxel injection intravenous infusion","slug":"paclitaxel-injection-intravenous-infusion","indication":"Metastatic carcinoma of the ovary","status":"phase_3"}]}],"pipeline":[{"name":"LM-108 in combination with Toripalimab","genericName":"LM-108 in combination with Toripalimab","slug":"lm-108-in-combination-with-toripalimab","phase":"phase_3","mechanism":"LM-108 combined with Toripalimab works by blocking immune checkpoints to enhance anti-tumor immunity, with LM-108 targeting a specific immune pathway while Toripalimab blocks PD-1.","indications":["Solid tumors (specific indications under investigation in Phase 3)"],"catalyst":""},{"name":"Paclitaxel injection intravenous infusion","genericName":"Paclitaxel injection intravenous infusion","slug":"paclitaxel-injection-intravenous-infusion","phase":"phase_3","mechanism":"Paclitaxel stabilizes microtubules by binding to β-tubulin, preventing their depolymerization and causing cell cycle arrest and apoptosis in cancer cells.","indications":["Metastatic carcinoma of the ovary","Breast cancer (metastatic and adjuvant)","Non-small cell lung cancer","Kaposi's sarcoma","Gastric adenocarcinoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNMW1HWGJMWlo5dEdhYUFIaUNGWHlvN1N6Vkp6ZUF5bm9NU2I5SENjM2tyZXRMS05aUm5RaXBiXzhGLUpHNURTZ19oZWF4WWdSb08xa1pWY01UdjAyX3U0ZXM0cm00MTRfUXVBRnJFVnlZNnEtRk9YVWRDaW14SlhvODVfZ2hGVlhVWDBQdjNsYjExZmRBQ2RWZ2F4dFhUcm9SRERpcUp5RQ?oc=5","date":"2025-12-23","type":"pipeline","source":"BioWorld News","summary":"Big pharma taps fast Asia innovation in search of next Keytruda - BioWorld News","headline":"Big pharma taps fast Asia innovation in search of next Keytruda","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPVVRucTlhdkxaRm9TSGxENkRvZE1aREw2NDd1a0ZNajNfclRkZVdaWjhMUFRoNkdpZnJoVUFhRTI3R0xpS3R0NV82Qzh4TzUxaVBrYmwwVWNTUWRaZkswYmZFZ0ppTmNzX3RWZVRtRVRFRmlvVmV5YUNwa3d1UFZTM0d1dGU4R0p2aTgtMS0tdDhkZ3E3dWhOZ3lfNXlNQnVvSW10VllNZFdQTUE4dlpJLTh4STlLb25CNVQxUE5EamswZmlh?oc=5","date":"2025-10-24","type":"deal","source":"BioCentury","summary":"LaNova’s Crystal Qin wins woman leadership prize as dealmakers shape BayHelix awards - BioCentury","headline":"LaNova’s Crystal Qin wins woman leadership prize as dealmakers shape BayHelix awards","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNTERJZ25jc1NPd3BYMzBNc3k1RUttSWdxNUVVUzRiUVNtZUJjTGljTTNEN0lLNkItQklPeWx4cWJWS29wSXpuWXZzSFkydE05eVVmamJna2RHaEFONHRMTld6MGoxTlZJcWNmdFUyMFA4aU5UbVJnalM1NDMyT0VUSk40MHlDTm1kdXE4SXZ2ZkNWcmZmU0xBM3I2Wm9nYTBlNjlGMEtIQVZ5aWhpYnc?oc=5","date":"2025-07-18","type":"deal","source":"Fierce Pharma","summary":"Fierce Pharma Asia—China biotech deal boom; Takeda's narcolepsy win; Sino Biopharm's LaNova buyout - Fierce Pharma","headline":"Fierce Pharma Asia—China biotech deal boom; Takeda's narcolepsy win; Sino Biopharm's LaNova buyout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPMXA3M180R2tZc0Rlem1JZlJLdFp1b1JOX0VGXzdyaFAwdXVMeE9ubi1pbGszSUU5V3RmUnprcERkTUlaMnZLRXlDWkxMenVDRWpfek14RWc0WVJPU2RIVWFLVWVvaWhpbW5hWlA5OG90eGFjVkRTQWxYWjd0R0duOWx2Zw?oc=5","date":"2025-07-16","type":"deal","source":"pharmaphorum","summary":"MSD, AZ partner LaNova bought by Sino Biopharm for $951m - pharmaphorum","headline":"MSD, AZ partner LaNova bought by Sino Biopharm for $951m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOR0pvMzJlOGk4UVB3RU9weFdwWGZVSW90SGlVN2laVFpHc0MtQnlIdW9GMjlDMV85Ui1WU0lrWWRNeGJPTnozUnI5VEFnU1RGNkg3bGI4NkgyUjhEeWw2bnptbjFkeDhwQjRUVk1fUE5BQ25TVFl2cTdsc1JyckRSb3hKdFd1NW56Nm9LZDlseFFiQld1ckV6d3JmYk1ybVoyYXlGQlZVc1IycGFyck45RkgyZVIxYm1tY21vaUtJTkpBZUVQUXhxNm5WWXFnNTg?oc=5","date":"2025-07-15","type":"deal","source":"Reuters","summary":"Sino Biopharmaceutical to acquire LaNova Medicines for up to $951 million - Reuters","headline":"Sino Biopharmaceutical to acquire LaNova Medicines for up to $951 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPWkYwYmQtSVpYYWkxYnBVaE8xZlI4MzRIelJPYVdkU1JVQ01xUDJyRkRrQnVjTW1mR1FlbzZ6Q1lLUFB5QW5hSDJtOVEtZnVYQnlqX0JVS3BvQ2oxNnhJOWV5TXVJYVF2ejhZc1JSOU95VWIySWJ1M1o4RXFDZDZVZ1V4UUxtd3IzMHRIU0ROVUVHbnRpbzVJU0UwWVAtV0JUTGsyLWpjalVhXzEwcGliRGdqZi0?oc=5","date":"2025-07-15","type":"deal","source":"Pharmaceutical Technology","summary":"Sino Biopharma spends $951m to acquire China-based LaNova Medicines - Pharmaceutical Technology","headline":"Sino Biopharma spends $951m to acquire China-based LaNova Medicines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNV3dQdGlaT0ZxQlQ4TW1nRzhoMHpRR245YWFid2w3dUh2R1FNeUF5R1hTUHpwWFJIaVlnWHBoRUxvRmtrbjFka2g5ZGNEc3lfTEhlS3NuWkk3QmRZVjRfaWV2U2NzMVZxd3lGbC0wLU4zRW9Rdk03QU9GWW1Eb1Y4c204RjVFWGRsVnpOcGtXckFCYUotOHFSNlVsSGJWc1ExcFZHSnV3?oc=5","date":"2025-07-15","type":"deal","source":"Fierce Biotech","summary":"Sino Biopharm buys Merck's PD-1xVEGF bispecific partner LaNova for up to $951M - Fierce Biotech","headline":"Sino Biopharm buys Merck's PD-1xVEGF bispecific partner LaNova for up to $951M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQMWNvNzRfeHZlbUlsTTZUQWkwd2hxNnYxYTdVTldoM0t2ZTFfS3BHME9RZG12VTRHWFZ3SVcwUnZmSGdwSzkweFVhZW43RV9QQ0lQeWN3UWU1RzVIaHJIbkVOWGtrU2tkNV9UM2VaRUJFNUp5aFo0ZGZuYkJrYm9VWXBYYkJMWkcyRFlKNEN3WXVzRzBZOWxseS1IZlZOV3IxQ0E?oc=5","date":"2025-07-15","type":"deal","source":"BioCentury","summary":"Sino Biopharma acquires Lanova in rare China-China takeout - BioCentury","headline":"Sino Biopharma acquires Lanova in rare China-China takeout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNRUtaMHRDUnZ5MUNrbkljVzFXQ21nckxnTjJ4WUVWQ0pmQmhHNjNvNlFYcXVibWFwcDhtT0t6OGxNOTRJX1YwZUxvUmY0OFhRTzN5bTUzQWlkMUlKU2syek5RRGNXOTJiMFAzc1ZTRDZfSFRPMmNYYWc5aWdxbTQ0dHJoZGhkdlBJMElGZDliSUdFSENveThiLQ?oc=5","date":"2025-07-15","type":"pipeline","source":"BioPharma Dive","summary":"Cancer drugmaker LaNova to sell to China’s Sino Biopharm - BioPharma Dive","headline":"Cancer drugmaker LaNova to sell to China’s Sino Biopharm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQaElEY0lNV3pRTEpfSzVfNXdMS1JZM1JVdHZueTMzdVFJR0ZydFl1UUtLek5nbTFYd25mYTBSYWlxT3ZKNVNyTnp0djBNWXhSbk1kTWdCY0pKOUFSWktEVXd1WFBuR1Z4dXExOGJnX2M3YU9SVHRTWC1aZm1acG9JT0ZSS0RBb0tUWE91SmtWa1pPcXNpNENPUS1yR3lxZTdQSXZmbENBNDE?oc=5","date":"2024-11-14","type":"deal","source":"BioSpace","summary":"Merck Hops Onto PD-1/VEGF Train, Committing up to $3B Plus in LaNova Deal - BioSpace","headline":"Merck Hops Onto PD-1/VEGF Train, Committing up to $3B Plus in LaNova Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQMzE1b0MwWGJvMVBIVzVjY0x4Wm85cFhYOGpXS1N3SlQ0azk1eHdzMG1CZEVEc2tWYk5lamxDT2tzMXZVSHE0ZjhtTEJVd3BkcVlOZnVnU1diZms2bF81Wnc2TkVTeWdRQjNiOGJSazVMdDk4WVc3MlJrb2xQSm5NMjQ0akVpZTBfdks1bVNvNklfanFrcWNOT0Q3TGwtSHNqd0JxcTVMTGkxTTJLLVZ4SFVYTTQ?oc=5","date":"2024-11-14","type":"deal","source":"Bloomberg.com","summary":"Merck Snags Chinese Cancer Drug in Deal Worth Up to $3.3 Billion - Bloomberg.com","headline":"Merck Snags Chinese Cancer Drug in Deal Worth Up to $3.3 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPd3habVNkeEJ5czN3TFhORU5ldFRxRVVhYlZaMDFjX3FHUGl2c3MtbmJyNDJib05DVzdaeUFUdFNsVEFrcVBaMTUyMkpvOGE5Y3gzYWxSX0ZsMHhrSXp6Q3ludlQ3SGJLNVduZTRVUGhINEtCT3BTbUNHbEkyRzFPNzk3TUhtNUMyd0RDS1cwWjJzd3lrbGtPWTJZSTUyYzdGYnRvQmpWYVNWUkpLZ0Q1Y294bWVmdDV1S1pNWXdlQmJudkg4ZzY3LXdQc1ROU2x1QWtDNzNHTTZTLXdRNUlCWEdycw?oc=5","date":"2024-10-21","type":"trial","source":"BioPharma APAC","summary":"LaNova Medicines Initiates Phase 1 Trial of Anti-PD-1/VEGF BsAb LM-299 in China for Advanced Solid Tumors - BioPharma APAC","headline":"LaNova Medicines Initiates Phase 1 Trial of Anti-PD-1/VEGF BsAb LM-299 in China for Advanced Solid Tumors","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}